ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,589Medicare Part D Prescriptions Filled, Including Refills
$1.26M Total Retail Price of All Prescriptions
674 Patients Receiving at Least One Drug in Part D
35%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 1,928 638 S3
OXYCODONE HCL 1,503 384 S2
METHADONE HCL 965 243 S2
GABAPENTIN 855 261
OXYCODONE HCL-ACETAMINOPHEN 477 146 S2
OXYCONTIN 401 91 S2
FENTANYL 399 187 S2
CYCLOBENZAPRINE HCL 375 73 R
CARISOPRODOL 325 33 R
OPANA ER 293 51 S2
TIZANIDINE HCL 272 28
ZOLPIDEM TARTRATE 266 47
MELOXICAM 251 63
LYRICA 200 55
MORPHINE SULFATE ER 178 37 S2
CYMBALTA 165 37
PROMETHAZINE HCL 153 36 R
OXYCODONE-ACETAMINOPHEN 149 63 S2
TOPIRAMATE 145 21
HYDROMORPHONE HCL 145 26 S2
BACLOFEN 135 0
IBUPROFEN 122 13
AMITRIPTYLINE HCL 110 27 R
LIDODERM 108 20
MORPHINE SULFATE 102 27 S2
TRAMADOL HCL 91 49
ENDOCET 81 22 S2
CELEBREX 69 26
OXYMORPHONE HCL 69 0 S2
AVINZA 65 33 S2
SAVELLA 61 0
TRAZODONE HCL 60 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.